Thierry Burnouf: Platelet-Derived Products as Acellular Biotherapies for Neurological Disorders
Thierry Burnouf, Vice-Dean, Distinguished Professor, Biomedical Engineering at Taipei Medical University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I am pleased to share our new review in Trends in Molecular Medicine:
‘Platelet-derived and platelet secretome biotherapies for precision neuromedicine’.
In this article, we discuss how platelet-derived products, including platelet lysates, secretome fractions, and extracellular vesicles, may offer a new platform for the development of acellular biotherapies for neurological disorders.
Their multimodal composition may help address complex disease mechanisms involving neuroinflammation, oxidative stress, ferroptosis, synaptic dysfunction, and impaired neurogenesis.
The review also discusses how omics-guided fractionation and pre-clinical data, biomarker development, and imaging approaches may help move these products toward more precise and standardized clinical applications.
Many thanks to all co-authors (MingLi Chou, David Blum, Fabrice Cognasse, Grégory Kuchcinski, David Devos, Thierry Burnouf) involved in this work, and in the pre-clinical and clinical development of platelet biotherapies for the treatment of brain diseases.”
Title: Platelet-derived and platelet secretome biotherapies for precision neuromedicine
Authors: Ming-Li Chou, David Blum, Fabrice Cognasse, Grégory Kuchcinski, David Devos, Thierry Burnouf
Read the Full Article on Trends in Molecular Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 30, 2026, 14:21Mohamed Sikkander Abdul Razak: Addressing Underdiagnosis of Bleeding Disorders in Women With Heavy Menstrual Bleeding
-
Mar 30, 2026, 14:20William Aird: Thinking Before Searching in Clinical Decision Making
-
Mar 30, 2026, 14:11Chokri Ben Lamine: Strategic Decision Making in Hematology under Competing Risks
-
Mar 30, 2026, 14:10Erwin Loh: Primary Prevention of Cardiovascular Events With Evolocumab in High-Risk Patients With Diabetes
-
Mar 30, 2026, 13:59David McIntosh: How European Plasma Policy Shapes Global Access to Life-Saving Therapies
-
Mar 30, 2026, 13:27Stephanie A. Haddad: Improving Access in Fertility Preservation for AYA Hematology/Oncology Patients
-
Mar 29, 2026, 16:17Ammara Mushtaq: How Research Fills the Gaps in Fast Paced Healthcare
-
Mar 29, 2026, 16:16Pete Stibbs: Insights from the 32nd World Congress of the International Union of Angiology
-
Mar 29, 2026, 16:15Davide Capodanno: Independent Investigators Lead the First Head to Head DOAC Comparison